LIGAND PHARMACEUTICALS INCORPORATED
Net Cash Flow Breakdown
Total Cash from Operations: $253.3M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $63.2K | 0.0% |
| Other Investing | $34.0M | 13.4% |
| Working Capital | $203.2M | 80.2% |
| Other | $16.0M | 6.3% |
| Net Cash Flow | $0 | 0.0% |